Cipralex vs. placebo (GAD)

Mean change from baseline in HAM-A total score (ref.1) * Significantly different from placebo, p<0.05 ** Significantly different from placebo, p<0.01 *** Significantly different from placebo, p<0.001

• Significant improvements in GAD symptoms were seen from week 1 onwards in patients treated with escitalopram (10 mg/day) compared with placebo.

Kaplan-Meier estimate (ref.2)

• Escitalopram (20mg/day) significantly reduced the risk of relapse compared with placebo.

---

References:

1. Davidson et al., 2004a; data on file

2. Allgulander et al., 2005